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Abstract
Background: Despite the increasing use of laparoscopic techniques, the optimal surgical approach for
cystic liver disease has not been well defined. This study aims to determine the optimum operative
approach for these patients.
Methods: Data were identified from the Lothian Surgical Audit, case note review and general practitioner
contact. Patients were contacted and asked to complete the SF-36 questionnaire on quality of life.
Results: A total of 102 patients (67 with simple cysts, 31 with polycystic liver disease [PCLD], four with
cystic tumours) underwent 62 laparoscopic deroofings, 15 open deroofings, 36 resections and one liver
transplant between June 1985 and April 2006. The median follow-up was 77 months (range 3–250
months). Morbidity and recurrent symptom rates after laparoscopic surgery were greater in PCLD patients
compared with simple cyst patients, at 31% (four patients) vs. 15% (seven patients) and 85% (11 patients)
vs. 29% (24 patients), respectively. Four patients with simple cysts and eight with PCLD required further
surgery. All patients with simple cysts had comparable quality of life after surgery. Patients with recurrent
symptoms after surgery for PCLD had a significantly better quality of life following laparoscopic deroofing
than after resection.
Conclusions: Most simple cysts can be managed laparoscopically, but there is a definite role for open
resection in some patients. Open deroofing is the preferred approach for a dominant cyst pattern in
PCLD, whereas resection is necessary for diffuse cystic disease.
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Introduction
Non-parasitic cystic disease of the liver occurs in up to 5–10% of
the population, with a sharp rise in incidence with age.1 The
pathogenesis is related to the type of cyst. Simple cysts may be
solitary or multiple, are lined by cuboidal epithelium and are
believed to arise from the abnormal development of intrahepatic
bile ducts in utero.2 Polycystic liver disease (PCLD) is an autosomal
dominant disease characterized by mutations on two genes on
chromosome 19.3 Patients with PCLD may also have cysts in other
organs, particularly the kidneys. Neoplastic cysts (benign biliary
cystadenomas and biliary cystadenocarcinomas) are acquired, but
the cause is unknown. Traumatic cysts are also acquired and result
from bile leakage from an injured intrahepatic bile duct after
trauma.
The majority of patients with non-parasitic hepatic cysts are
asymptomatic and the cysts may be found incidentally at laparo-
tomy or with abdominal imaging. However, 5% of patients are
symptomatic4 and present with non-specific symptoms such as
pain, nausea, vomiting, early satiety or heartburn. Rarely, cysts can
present as a result of complications such as haemorrhage,5 rup-
ture,6 infection,6 torsion,7 portal hypertension,8 malignancy9 and
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obstructive jaundice.10 In symptomatic or complicated cases it is
usual to intervene and the procedures available include percuta-
neous aspiration with ethanol injection, laparoscopic deroofing,
open deroofing, hepatic resection and transplantation. There is
considerable controversy as to which procedure is preferable.11
Laparoscopic deroofing was first reported in 1991,12 and most
studies seem to agree that it is the treatment of choice for simple
cysts. However, recurrence rates vary greatly, from 0%13 to 25%.14
Other studies have suggested that open deroofing and resection
are better operations.15,16 There is no accepted best approach for
the treatment of patients with PCLD. In these patients, laparo-
scopic deroofing leads to recurrence rates of 60%17 to 100%,18
whereas resection and transplantation have lower recurrence
rates,18 but are associated with significantly higher morbidity
rates.19 Moreover, the different surgical interventions have never
been correlated with postoperative quality of life. The aim of this
study was to evaluate all patients who underwent operative pro-
cedures for liver cysts in a specialist centre and to determine the
most favourable operative approach in terms of morbidity, recur-
rence and quality of life.
Materials and methods
All patients who underwent operations for non-parasitic hepatic
cysts were identified from the Lothian Surgical Audit20 and the
department’s own prospective database. The case notes, radiology
reports, operation notes, pathology reports and blood results were
reviewed retrospectively for all patients. Patient gender, age at first
operation, presenting symptoms, preoperative blood results and
final pathology were documented. All patients who fulfilled the
diagnostic criteria for PCLD (chromosome 19 mutations) were
included in this subgroup for analysis. In the vast majority of
patients, the diagnosis was established prior to referral to the
surgical team. All other patients were labelled as having simple
cysts. The number and location of the cysts and the size of the
dominant cyst were recorded. The type and duration of the opera-
tion, complications, length of postoperative stay and follow-up
were also documented. Patients were contacted by telephone to
enquire about recurrent symptoms and were sent an adapted
SF-36 questionnaire, as a health survey and quality of life
assessment.21–23 The answers were scored using a scoring system
developed by RAND Health (http://www.rand.org/health/
surveys_tools/mos/mos_core_36item.html; RAND Corp., Cam-
bridge, UK), which ranges from 0 to 3600, with a higher score
indicating a better quality of life.
Data were analysed using spss Version 13.0 (SPSS, Inc.,
Chicago, IL, USA). Statistical tests included the Kruskal–Wallis
test, Mann–Whitney U-test, chi-squared and Fisher’s exact test.
Values are given to the nearest whole number except for P-values,
which are given to three significant figures.
Results
Between June 1985 and April 2006, 102 patients with liver cysts
underwent 114 surgical procedures. Demographic data, size of the
dominant cyst, cyst location(s) and lobar distribution according
to type of disease are presented in Table 1. A total of 99 patients
(97%) were symptomatic; the frequency of presenting symptoms
is documented in Table 2. The remaining three asymptomatic
patients underwent surgery for associated pathology (two had
liver metastases and one had a rapid increase in the size of the cyst
and required cholecystectomy for symptomatic gallstones). In this
series, 63 patients (62%) with simple cysts had multiple cysts
(more than three). Liver function tests were abnormal in almost
one-third of patients (in 21 patients [32%] with simple cysts and
in nine patients [29%] with PCLD). Twenty-one of the 31 patients
(68%) with PCLD also had kidney cysts.
Twelve patients in the simple cysts group underwent one or
more attempts at percutaneous aspiration at a median of 6.5
months prior to surgery, whereas nine patients in the PCLD
group underwent attempted aspiration of the dominant cyst at a
median of 6 months prior to surgery. Operative details and
related postoperative morbidity are shown in Table 3. Two
patients with simple cysts who underwent laparoscopic deroof-
ing had further surgery (one open deroofing and one resection)
and two patients who had open deroofing underwent a further
open deroofing (one) and a resection (one). In the PCLD group,
seven resections were carried out as a secondary procedure (two
Table 1 Demographic data, size of cyst and location of the dominant cyst in 102 patients who underwent operations for non-parasitic hepatic
cysts
Demographics Simple cysts (n = 67) PCLD (n = 31) Cystadenoma (n = 3) Cystadenocarcinoma n = 1
Median age, years (range)a 60 (29–84) 49 (33–85) 39 (38–40) 52
Sex, M : Fa 8 : 59 2 : 29 0 : 2 0 : 1
Median size, cm (range)a 11 (2–30) 10 (4–18) 12.7 (9.4–16)
Bilateral location, % 23 100 10
Right hemiliver, % 25 0 100
Left hemiliver, % 14 0 0
Unknown, % 38 0 0
aNo statistical significant differences
PCLD, polycystic liver disease; M, male; F, female
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after open deroofing and five following laparoscopic deroofing).
One patient who underwent an initial laparoscopic deroofing
had a subsequent open deroofing followed by resection. One
patient who underwent laparoscopic deroofing was found on
pathological examination of the cyst wall to have a cystadenoma
and subsequently underwent a major hepatic resection. All pro-
cedures were performed without any operative or perioperative
mortality. The 34 resections included 28 hepatectomies, four left
lateral sectionectomies and one segment III resection. Laparo-
scopic cholecystectomy was performed in 18 patients who
underwent laparoscopic deroofing. The only transplant proce-
dure in this series was carried out as a combined liver and
kidney transplant.
Operative times for laparoscopic deroofing and open deroofing
were comparable (P = 0.560). However, the operative time was
significantly longer for resection (P < 0.016) compared with either
laparoscopic or open deroofing (Table 3). These findings were
similar in patients with simple cysts and those with PCLD. A
laparoscopic approach translated into a shorter postoperative stay
for simple cystic disease and PCLD (P < 0.05), whereas open
deroofing and resection resulted in comparable lengths of post-
operative stay (P = 0.600).
Overall, laparoscopic deroofing was associated with postopera-
tive complications in 10 patients (16%). These included: pyrexia
(n = 2); chest infection (n = 2); bile leak (n = 2); pleural effusion (n
= 1); pneumothorax after central line insertion (n = 1); deep vein
thrombosis and pulmonary embolism (n = 1) and myocardial
infarction (n = 1). Complications after open deroofing included
five chest infections and one pleural effusion. Fourteen patients
developed complications after resection, including: pleural effu-
sion (n = 7); bile leak (n = 2; one persistent); chest infection (n =
2); pyrexia (n = 1); prolapsed omentum at the drain site (n = 1),
and pancreatitis (n = 1). The persistent bile leak required a hepati-
cojejunostomy 8 months later. Post-transplant complications
included a chest infection complicated by MRSA (multiple-
resistant Staphylococcus aureus), respiratory failure, gross periph-
eral oedema and post-traumatic stress disorder. Correlations
between morbidity, type of cyst and type of surgical procedure are
shown in Table 3. There were no statistical differences between
procedures according to type of cyst.
The median follow-up was 77 months (range 3–250 months).
Seventy-four patients were contacted by telephone and inter-
viewed about symptom recurrence. Data for the remaining
patients were obtained from the last follow-up letters. Table 4
Table 2 Presenting symptoms in 102 patients who underwent operations for non-parasitic hepatic cysts
Symptom Simple cysts (n = 67) PCLD (n = 31) Cystadenoma (n = 3) Cystadenocarcinoma (n = 1)
Pain (%) 55 (82) 29 (94) 3 (100) 3 (100)
Bloating (%)a 16 (24) 17 (56) 0 0
Nausea (%) 15 (22) 10 (34) 0 0
Vomiting (%) 5 (8) 4 (13) 0 0
Early satiety (%) 12 (18) 10 (34) 1 (33) 0
Fatigue (%) 12 (18) 10 (34) 0 0
Shortness of breath (%) 7 (11) 6 (19) 0 0
Palpable mass (%)a 22 (33) 24 (78) 0 0
Heartburn (%) 0 0 1 (33) 0
Asymptomatic (%) 3 (4) 0 0 0
aDenotes statistical significant differences between simple cysts and PCLD, P < 0.005
PCLD, polycystic liver disease
Table 3 Operative details in patients with non-parasitic hepatic cysts. Data are given as median (range)
Pathology Operation n Operation time, mins Postoperative stay, days Morbidity, n (%)
Simple cysts Laparoscopic deroofing 48 75 (40–170) 3 7 (15)
Open deroofing 11 90 (40–120) 8 3 (30)
Resection 12 155 (90–295) 10 5 (42)
PCLD Laparoscopic deroofing 13 105 (40–180) 4 4 (31)
Open deroofing 11 110 (60–150) 12 4 (40)
Resection 21 217 (90–360) 17 9 (43)
Transplant 1 494 26 1 (100)
Cystadenoma Laparoscopic deroofing 1 Unknown 1 0
Resection 2 255 13 0
PCLD, polycystic liver disease
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shows the proportion of patients with recurrent symptoms and
time to recurrence after initial surgery.
Laparoscopic deroofing was associated with a significantly
higher rate of symptom recurrence in PCLD patients compared
with those with simple cysts (11 [85%] vs. 14 patients [29%]; P =
0.001, two-tailed chi-square). Furthermore, when compared with
open deroofing or resection in the PCLD group, laparoscopic
deroofing was associated with the highest rate of symptomatic
recurrence, although this did not reach statistical significance.
However, recurrent symptoms were less severe than those prior to
the initial surgery according to patient responses in the follow-up
questionnaire.
Overall, symptom recurrence was markedly reduced in the 39
patients who had fewer than three cysts compared with the 63
patients with three or more cysts (14% vs. 42%; P = 0.02, two-
tailed chi-square). Only four of the 67 patients who underwent
surgery for simple cysts required further surgical intervention,
compared with nine of the 31 patients with PCLD (P = 0.011,
two-tailed chi-square). Ninety SF-36 questionnaires (88%) were
mailed out because nine patients were deceased and no contact
addresses were available for the remainder. Sixty-four (71%) were
returned (three patients were unable to complete the question-
naire). Overall, for patients with simple cysts there were no statis-
tical differences in quality of life according to type of surgery
(anova, P = 0.605), although the more complex the procedure,
the higher the mean score (Fig. 1A). Similarly, there was no sta-
tistical difference in quality of life by type of surgery among PCLD
patients (anova, P = 0.700), but the mean scores showed an
opposite trend (Fig. 1B). However, the quality of life of patients
with PCLD who had recurrent symptoms after laparoscopic
deroofing was significantly better than that of patients who under-
went resection, as confirmed by higher physical (Student’s t-test, P
= 0.010) and psychological scores (Student’s t-test, P = 0.006).
Discussion
Because of the low incidence of symptomatic hepatic cysts in the
general population, there has been no consensus on the optimal
approach to management of cystic liver disease and therefore
patients are managed on an individual basis. Several studies have
attempted to address this problem, but numbers of patients and
lengths of follow-up have varied significantly and results are
sometimes conflicting. The current study aims to address this
issue from a single-centre perspective with experience from
the second largest series of non-parasitic hepatic cysts in the
literature.
In the management algorithm for patients with cystic disease,
the clinician must be certain of the diagnosis and determine the
Table 4 Recurrence following initial surgery in patients with non-parasitic hepatic cysts
Pathology Operation n Patients with recurrent
symptoms, n (%)
Time to recurrence,
months
Patients who had
further surgery, n (%)
Simple cysts (n = 67) Laparoscopic deroofing 48 14 (29) 19 2 (4)
Open deroofing 11 4 (36) 6 2 (18)
Resection 12 3 (27) 12 0
PCLD (n = 31) Laparoscopic deroofing 13 11 (85) 25 6 (46)
Open deroofing 11 6 (55) 12 3 (27)
Resection 21 10 (48) 28 0
Transplant 1 0 N/A 0
Cystadenoma (n = 3) Laparoscopic deroofing 1 0 N/A 1 (100)
Resection 2 50 5 0
PCLD, polycystic liver disease; N/A, data not available
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and (B) polycystic liver disease
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precise indication for surgery. It is widely accepted that symptoms
are non-specific and the diagnosis is one of exclusion, which
involves ruling out other significant pathology. Even so, concur-
rent pathology, such as gallstone disease, may be present; in this
series, four patients (4%) were found to have co-existing gall-
stones. In the current series, almost one-third of patients had
abnormal liver function tests. This association was one of the
reasons for intervention in patients with small simple or PCLD
cysts. An additional concern is the presence of malignancy.
Although the radiological characterization of cyst pathology
before surgery is generally accurate, a high index of suspicion for
the presence of a neoplastic cyst should be maintained. This dif-
ferentiation is even more difficult for simple cysts presenting with
intra-cyst haemorrhage and with unusual radiological appear-
ances, which could be mistaken for cystadenomas. The one case of
mistaken radiological diagnosis of a cystadenoma in the present
series supports the role for routine pathology examination of the
cyst wall. If the presence of a cystadenoma is confirmed after the
initial surgery, formal resection is required.
The second key question concerns the type of intervention, as
several options are available. The choice may reflect the type and
extent of cystic disease as well as the expertise and technology
available locally. Percutaneous drainage and ethanol injection are
increasingly used in some centres for patients with smaller simple
cysts. The results are mixed and there appears to be a high recur-
rence rate. In the current series, 21 patients (12 with simple cysts
and nine with PCLD) underwent attempted aspiration – in some
cases combined with alcohol sclerosis – prior to referral. These
patients had undergone repeated interventions with limited relief
of symptoms. There seems to be little rationale for performing
aspiration alone other than in an attempt to establish whether a
specific cyst is symptomatic. Aspiration used in combination with
instillation of alcohol may be of value in patients with significant
co-morbidity or in those with a single small cyst which is symp-
tomatic. However, this study did not seek to address the role of
cyst aspiration and ethanol injection as the combination is not
common practice at present in our centre.
In the current era of minimally invasive surgery, laparoscopic
deroofing appears to be the preferred initial approach in most
centres for the treatment of simple cysts.24–26 However, others
prefer resection as the primary surgery and report no recurrence
and a 17% morbidity rate.16 This study, however, had few patients
and its follow-up period was too short to allow for the drawing of
meaningful conclusions regarding symptomatic recurrence. In the
current series, a laparoscopic approach was associated with a 15%
morbidity rate, a short postoperative stay and a low re-operation
rate compared with open deroofing. Furthermore, symptom
recurrence occurred sooner after open deroofing than after lap-
aroscopic deroofing. These results highlight some of the intrinsic
benefits of minimally invasive surgery. In the current study, all
open deroofing procedures were performed prior to 1999, since
when the preferred approach for simple liver cysts has been a
laparoscopic procedure.
It is important to highlight the presence of a group of patients
in whom hepatic resection was the primary intervention. This was
associated with similar postoperative morbidity rates but a 0%
re-operation rate, lower symptom recurrence rate and longer time
to recurrence compared with open deroofing. These findings chal-
lenge the suggestion that open deroofing is suitable as a second-
line treatment15 and, in fact, resection should be the preferred
management choice in a selected group of patients in whom a
laparoscopic technique is not feasible because of a multitude of
cysts or their location(s). For example, a centrally located large
cyst or a large posterior cyst may recur despite apparently
adequate laparoscopic or open deroofing because the roof may
reconstitute as the left and right hemilivers of the liver appose.
Because of this tendency to recurrence, these cysts may be better
managed by resection than by deroofing.
Several techniques to prevent cyst recurrence have been advo-
cated, including the placement of omentum in the residual cavity
or the ablation of the residual cyst lining. The utility of these
methods is questionable and none were used in the current series.
In patients with PCLD, the choice of initial surgical technique is
even more controversial as a result of the size and distribution of
the cysts as well as the severe distortion in liver anatomy. Since
1999, our unit has tended towards a laparoscopic approach in the
vast majority of simple cyst patients, but open deroofing or resec-
tion remained the primary approaches in PCLD and only a small
number of patients have undergone laparoscopic deroofing, even
after this date. In an attempt to rationalize the treatment, Gigot
et al.27 proposed a classification based on preoperative computed
tomography (CT) scanning and suggested that therapy should be
tailored to the type of disease. However, this classification is not
widely used by radiologists and, therefore, the lack of uniform
radiology reporting in the present series did not allow us to
analyse the type of treatment and the Gigot staging. We should
also point out that cyst size alone is of limited value when plan-
ning treatment strategy because multiple small cysts in a PCLD
patient are as likely to require intervention as a large solitary cyst.
Laparoscopic deroofing has been increasingly used in PCLD,
despite a high recurrence rate.17,18,28 In this series, laparoscopic
deroofing was the most successful operation in terms of operative
time, length of postoperative stay and morbidity. However, 85% of
those who underwent laparoscopic deroofing had recurrent
symptoms and 46% of these patients underwent further surgery.
Despite this, patients reported that recurrent symptoms were
milder than symptoms prior to initial surgery, which translated
into better physical and psychological quality of life scores com-
pared with those collected after resection. However, any decision
favouring laparoscopic deroofing should be carefully considered
and should weigh the extent of disease, patient co-morbidity and
the high risk of recurrence against the likely extent of improve-
ment in symptoms. In patients with a dominant cyst pattern, a
laparoscopic or open deroofing should be the preferred initial
treatment, taking into account all of the above factors, whereas
resection should be reserved for those with a diffuse cyst pattern.28
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Resection in these patients is technically challenging, but, as the
current data show, does not necessarily increase the risk; there is
little difference between the two options in terms of morbidity,
length of postoperative stay, symptom recurrence or quality of life.
There appeared to be a lower re-operation rate and a longer time
to recurrence in the resection group, which may well reflect the
more extensive decompression of normal liver parenchyma
achieved in these patients. Given the complexity of these patients,
treatment should be carried out in specialist hepatobiliary units to
ensure an adequate management algorithm for a successful
outcome.
The role of transplantation in the management of PCLD could
not be ascertained in the current study. However, there are
patients with a diffuse disease pattern in whom there is a minimal
amount of normal liver parenchyma associated with significant
distortion of the liver anatomy. For these patients, transplantation
may be the best course of action,19 particularly if symptoms result-
ing from the size of the polycystic liver and associated with
exhaustion, fatigue and cachexia are significant.
A treatment algorithm for the management of cystic liver
disease is suggested in Fig. 2.
There are little data concerning the quality of life of patients
who have undergone surgery for cystic liver disease. This study
provides an insight into how patients perceive the effects of
surgery during longterm follow-up. The SF-36 questionnaire
revealed no significant differences in terms of quality of life
between any of the surgical procedures for simple cysts or PCLD.
Although the results shown in Fig. 1 can be interpreted in many
ways, no definite conclusions can be drawn because the small
numbers in the analysis may be responsible for the lack of statis-
tical significance. However, it was interesting to note that, in PCLD
patients with recurrent symptoms, a more extensive initial proce-
dure such as resection was associated with lower physical and
psychological scores (i.e. lower quality of life scores) compared
with those who had undergone laparoscopic deroofing. One
might speculate that this may reflect patient disappointment after
an initially high level of expectation that a more complex proce-
dure might lead to better results. It should also be noted that the
patient with PCLD may exhibit ongoing symptoms caused by
renal involvement, which may be difficult to distinguish from the
liver component. The challenges inherent in the management of
cystic liver disease should be fully discussed with patients and the
goals to be achieved with surgery should be identified on a case-
by-case basis.
This study is limited because it did not include patients with
cystic liver disease that was managed conservatively or using
percutaneous methods, and conclusions are drawn in terms of
symptom recurrence, rather than radiological recurrence. Many
patients had no radiological follow-up, whereas others had only
residual cysts on follow-up, as opposed to recurrence of the cysts
which had been operated on. However, the significance of radio-
logical recurrence in the context of no symptomatic recurrence
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Figure 2 Management algorithm for non-parasitic liver cysts
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remains to be determined. An in-depth analysis is difficult because
of various factors and rigorous prospective evaluation may not be
possible if patients fail on one type of intervention and require
further procedures. Finally, because of the nature of the study,
there was no baseline assessment of quality of life prior to the
initial surgical intervention and therefore correlations between
quality of life post-surgery and the extent of preoperative symp-
toms could not be assessed. The assessment presented here simply
identifies the quality of life as perceived by patients at different
time-points during follow-up.
In summary, the majority of simple liver cysts can be managed by
a laparoscopic approach but there is a definite role for open resec-
tion in selected patients. In patients with PCLD, open deroofing is
the preferred approach for a dominant cyst pattern, whereas
hepatic resection or, indeed, liver transplantation may be necessary
for disease with a diffuse cyst pattern. The management of non-
parasitic cystic liver disease has evolved with the development of
new surgical technologies, but remains challenging and offers a
prospect of high recurrence rates. Treatment should be undertaken
in specialist hepatobiliary units to ensure high rates of success.
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